Share the post "Rossari Biotech : Q1 2024 Financial Quarterly Report : YoY Sales Up 19.25 %, QoQ Up 3.58 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 19.25 % in the past year, substantial increase in net sales/revenue by 3.58 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -45.79 %, Marginal increase in other income during this quarter, up by 103.51%.
- Profit over the Year and quarter: Significant improvement in profitability for Rossari Biotech Limited. Notable increase of 19.44 % in net profit Year to Year, Rossari Biotech Limited’s profitability increased by 2.25 % in this quarter.
- EPS over the Year and quarter: EPS increased by 19.25 % Year to Year. EPS increased by 2.27 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 410.606 Cr | Rs. 472.715 Cr | Rs. 489.65 Cr | + 3.58 % | + 19.25 % |
| Expenses | Rs. 352.86 Cr | Rs. 409.13 Cr | Rs. 424.76 Cr | + 3.82 % | + 20.38 % |
| Operating Profit | Rs. 57.75 Cr | Rs. 63.59 Cr | Rs. 64.89 Cr | + 2.04 % | + 12.36 % |
| OPM % | 14.06 % | 13.45 % | 13.25 % | -0.2 % | -0.81 % |
| Other Income | Rs. 2.14 Cr | Rs. 0.57 Cr | Rs. 1.16 Cr | + 103.51 % | -45.79 % |
| Interest | Rs. 6.32 Cr | Rs. 2.52 Cr | Rs. 3.69 Cr | + 46.43 % | -41.61 % |
| Depreciation | Rs. 14.11 Cr | Rs. 16.07 Cr | Rs. 15.37 Cr | -4.36 % | + 8.93 % |
| Profit before tax | Rs. 39.46 Cr | Rs. 45.57 Cr | Rs. 46.99 Cr | + 3.12 % | + 19.08 % |
| Tax % | 25.92 % | 25.2 % | 25.84 % | + 0.64 % | -0.08 % |
| Net Profit | Rs. 29.22 Cr | Rs. 34.13 Cr | Rs. 34.9 Cr | + 2.26 % | + 19.44 % |
| EPS in Rs | Rs. 5.28 | Rs. 6.17 | Rs. 6.3 | + 2.11 % | + 19.32 % |
Today, we’re looking at Rossari Biotech Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 19.25 %. However, it did see a marginal increase of 3.58 % from the previous quarter. Expenses ticked up slightly by 3.82 % quarter-on-quarter, aligning with the annual rise of 20.38 %. Operating profit, while up 12.36 % compared to last year, faced a quarter-on-quarter increase of 2.04 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.81 %, but a shrinkage of -0.2 % sequentially. Other income rose by 103.51 % compared to the last quarter, despite an annual decline of -45.79 %. Interest expenses surged remarkably by 46.43 % from the previous quarter, yet the year-over-year decrease remains at a moderate -41.61 %. Depreciation costs fell by -4.36 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 8.93 %. Profit before tax grew annually by 19.08 % but saw an increase from the preceding quarter by 3.12 %.
Tax expenses as a percentage of profits decreased slightly by -0.08 % compared to last year, with a more notable quarter-on-quarter increase of 0.64 %. Net profit rose by 19.44 % year-on-year but experienced a 2.26 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 19.32 % but a quarterly rise of 2.11 %. In summary, Rossari Biotech Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 410.606 Cr | Rs. 472.715 Cr | Rs. 489.65 Cr | + 3.58 % | + 19.25 % |
| Expenses | Rs. 352.86 Cr | Rs. 409.13 Cr | Rs. 424.76 Cr | + 3.82 % | + 20.38 % |
| Operating Profit | Rs. 57.75 Cr | Rs. 63.59 Cr | Rs. 64.89 Cr | + 2.04 % | + 12.36 % |
| Net Profit | Rs. 29.22 Cr | Rs. 34.13 Cr | Rs. 34.9 Cr | + 2.26 % | + 19.44 % |
| EPS in Rs | Rs. 5.28 | Rs. 6.17 | Rs. 6.3 | + 2.11 % | + 19.32 % |
In reviewing Rossari Biotech Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 19.25 % year-on-year growth, however, there was a minor increase of 3.58 % from the previous quarter. Expenses rose by 20.38 % compared to the previous year, with a 3.82 % increase quarter-on-quarter. Operating Profit surged by 12.36 % annually, and saw a 2.04 % increase from the last quarter.
Net Profit showed yearly increase of 19.44 %, and experienced a 2.26 % increase from the previous quarter. Earnings Per Share (EPS) rose by 19.32 % annually, however rose by 2.11 % compared to the last quarter. In essence, while Rossari Biotech Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
